| __timestamp | Bausch Health Companies Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 406114000 |
| Thursday, January 1, 2015 | 2682700000 | 449119000 |
| Friday, January 1, 2016 | 2810000000 | 502892000 |
| Sunday, January 1, 2017 | 2582000000 | 544156000 |
| Monday, January 1, 2018 | 2473000000 | 683530000 |
| Tuesday, January 1, 2019 | 2554000000 | 736942000 |
| Wednesday, January 1, 2020 | 2367000000 | 854233000 |
| Friday, January 1, 2021 | 2624000000 | 1451683000 |
| Saturday, January 1, 2022 | 2625000000 | 1416967000 |
| Sunday, January 1, 2023 | 2917000000 | 1343105000 |
Cracking the code
In the competitive landscape of pharmaceuticals, understanding the financial strategies of industry players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Jazz Pharmaceuticals plc and Bausch Health Companies Inc. over the past decade.
From 2014 to 2023, Bausch Health consistently outspent Jazz Pharmaceuticals in SG&A, with expenses peaking at approximately $2.9 billion in 2023. This represents a 44% increase from their 2014 figures. In contrast, Jazz Pharmaceuticals saw a more dramatic rise, with their SG&A expenses more than tripling, reaching around $1.3 billion in 2023.
These trends highlight differing strategic priorities: Bausch Health's steady investment in SG&A suggests a focus on maintaining market presence, while Jazz Pharmaceuticals' rapid increase may indicate aggressive expansion efforts. Understanding these dynamics can provide valuable insights for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Bausch Health Companies Inc.
Comparing SG&A Expenses: Johnson & Johnson vs Bausch Health Companies Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Selling, General, and Administrative Costs: Halozyme Therapeutics, Inc. vs Bausch Health Companies Inc.
Blueprint Medicines Corporation and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Bausch Health Companies Inc. vs ImmunityBio, Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights